The Lamkin Clinic, an Oklahoma-based provider of integrative, long-term healthcare solutions rooted in functional medicine, announced on Friday that those seeking help with depression or anxiety in Oklahoma can now benefit from a new, FDA-cleared, medication-free procedure.
According to the clinic, it is one of the first in Oklahoma to offer EXOMIND, a non-invasive brain stimulation treatment that is claimed to enhance mental wellness. With EXOMIND, an applicator delivers gentle magnetic pulses to stimulate or suppress brain activity, targeting areas involved in emotional regulation, cognitive function, and self-control. It is claimed that patients frequently report improved sleep quality, higher energy levels and enhanced emotional resilience. Clinical studies have also shown additional benefits such as reduced food cravings and an average weight loss after six treatments.
In addition, The Lamkin Clinic offers advanced therapies designed to support whole-body health and recovery such as growth hormone therapies, biotoxin illness, medical weight loss, thyroid optimization, platelet rich plasma therapy, incontinence, and many more.
Zhimeng Biopharma's investigational drug gains Phase 2 epilepsy clinical trial approval in China
Sanofi's SAR402663 granted FDA fast track designation for wet AMD
Implantica produces 10,000 RefluxStop units ahead of planned US launch
Sobi's Biologics License Application for NASP in uncontrolled gout accepted by FDA
Ionis receives FDA Breakthrough Therapy designation for ION582 in Angelman syndrome
Saol Therapeutics receives US FDA Complete Response Letter for SL1009 (DCA) in PDCD